Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report

Author：              

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|4|1885-1888

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.4, 2015-01, pp. : 1885-1888

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pulsed reduced dose-rate radiotherapy: case report: A novel re-treatment strategy in the management of recurrent glioblastoma multiforme

By Cannon George   Tomé Wolfgang   Robins H.   Howard Steven  

Journal of Neuro-Oncology, Vol. 83, Iss. 3, 2007-07 ,pp. : 307-311

Springer Publishing Company

Access to resources Recommend Favorite

Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma

By Stockhammer Florian   Misch Martin   Koch Arend   Czabanka Marcus   Plotkin Michail   Blechschmidt Cristiane   Tuettenberg Jochen   Vajkoczy Peter  

Journal of Neuro-Oncology, Vol. 100, Iss. 3, 2010-12 ,pp. : 407-415

Springer Publishing Company

Access to resources Recommend Favorite

Combined chemotherapy with temozolomide and fotemustine in recurrent glioblastoma patients

By Gaviani Paola  

Journal of Neuro-Oncology, Vol. 104, Iss. 2, 2011-09 ,pp. : 617-618

Springer Publishing Company

Access to resources Recommend Favorite

Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study

By                  

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 799-801

Spandidos Publications

Access to resources Recommend Favorite

Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab

By Chamberlain Marc   Johnston Sandra  

Journal of Neuro-Oncology, Vol. 102, Iss. 3, 2011-05 ,pp. : 427-432

Springer Publishing Company

Access to resources Recommend Favorite